Aurinia Pharmaceuticals, Inc. (AUPH)

14.74 -0.30 (-1.99%) USD  |  NASDAQ  |  Mar 05, 16:00
14.70 -0.04 (-0.27%) After-Hours: 06:03
More

Aurinia Pharmaceuticals Pre-Tax Income (Quarterly)

Pre-Tax Income (Quarterly) Chart

View Pre-Tax Income (Quarterly) for AUPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Pre-Tax Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Pre-Tax Income (Quarterly) Range, Past 5 Years

View Pre-Tax Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Pre-Tax Income (Quarterly) Benchmarks

View Pre-Tax Income (Quarterly) Benchmarks
Start Trial
Xenon Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Edesa Biotech, Inc. Upgrade
Lexaria Bioscience Corp. Upgrade
ProMIS Neurosciences, Inc. Upgrade